Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Autophagy as a target for anticancer therapy
Filip Janků, David J. McConkey, David S. Hong, et al.
Nature Reviews Clinical Oncology (2011) Vol. 8, Iss. 9, pp. 528-539
Closed Access | Times Cited: 763

Showing 1-25 of 763 citing articles:

Autophagy: Renovation of Cells and Tissues
Noboru Mizushima, Masaaki Komatsu
Cell (2011) Vol. 147, Iss. 4, pp. 728-741
Open Access | Times Cited: 5658
Ageing as a Risk Factor for Disease
Teresa Niccoli, Linda Partridge
Current Biology (2012) Vol. 22, Iss. 17, pp. R741-R752
Open Access | Times Cited: 1557
Autophagy modulation as a potential therapeutic target for diverse diseases
David C. Rubinsztein, Patrice Codogno, Beth Levine
Nature Reviews Drug Discovery (2012) Vol. 11, Iss. 9, pp. 709-730
Open Access | Times Cited: 1369
Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment
Xinbing Sui, Rou-fen Chen, Zheng Wang, et al.
Cell Death and Disease (2013) Vol. 4, Iss. 10, pp. e838-e838
Open Access | Times Cited: 1118
Autophagy in malignant transformation and cancer progression
Lorenzo Galluzzi, Federico Pietrocola, José Manuel Bravo‐San Pedro, et al.
The EMBO Journal (2015) Vol. 34, Iss. 7, pp. 856-880
Open Access | Times Cited: 1090
Targeting the PI3K pathway in cancer: are we making headway?
Filip Janků, Timothy A. Yap, Funda Meric‐Bernstam
Nature Reviews Clinical Oncology (2018) Vol. 15, Iss. 5, pp. 273-291
Closed Access | Times Cited: 903
p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents
Xinbing Sui, Na Kong, Li Ye, et al.
Cancer Letters (2013) Vol. 344, Iss. 2, pp. 174-179
Closed Access | Times Cited: 877
The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects
Weiwei Tang, Ziyi Chen, Wenling Zhang, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 770
Autophagy and human diseases
Peidu Jiang, Noboru Mizushima
Cell Research (2013) Vol. 24, Iss. 1, pp. 69-79
Open Access | Times Cited: 741
Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway
Jiří Polívka, Filip Janků
Pharmacology & Therapeutics (2013) Vol. 142, Iss. 2, pp. 164-175
Closed Access | Times Cited: 732
Autophagy: The spotlight for cellular stress responses
Palaniyandi Ravanan, Ida Florance, Priti Talwar
Life Sciences (2017) Vol. 188, pp. 53-67
Closed Access | Times Cited: 547
Targeting PI3K/AKT/mTOR-mediated autophagy for tumor therapy
Zhenru Xu, Xu Han, Daming Ou, et al.
Applied Microbiology and Biotechnology (2019) Vol. 104, Iss. 2, pp. 575-587
Closed Access | Times Cited: 468
PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?
Yan Peng, Yuanyuan Wang, Cheng Zhou, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 464
Chloroquine in Cancer Therapy: A Double-Edged Sword of Autophagy
Tomonori Kimura, Yoshitsugu Takabatake, Atsushi Takahashi, et al.
Cancer Research (2013) Vol. 73, Iss. 1, pp. 3-7
Open Access | Times Cited: 463
Inside and out: the activities of senescence in cancer
Pedro A. Pérez–Mancera, Andrew Young, Masashi Narita
Nature reviews. Cancer (2014) Vol. 14, Iss. 8, pp. 547-558
Open Access | Times Cited: 444
Overcoming cancer therapeutic bottleneck by drug repurposing
Zhe Zhang, Li Zhou, Na Xie, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 433
The role of STAT3 in autophagy
Liangkun You, Zhanggui Wang, Hongsen Li, et al.
Autophagy (2015) Vol. 11, Iss. 5, pp. 729-739
Open Access | Times Cited: 432
mTOR: Role in cancer, metastasis and drug resistance
Avaniyapuram Kannan Murugan
Seminars in Cancer Biology (2019) Vol. 59, pp. 92-111
Closed Access | Times Cited: 402
Overcoming barriers in photodynamic therapy harnessing nano-formulation strategies
Jianlei Xie, Yingwei Wang, Wonseok Choi, et al.
Chemical Society Reviews (2021) Vol. 50, Iss. 16, pp. 9152-9201
Closed Access | Times Cited: 381
Regulation of autophagy by mTOR-dependent and mTOR-independent pathways: autophagy dysfunction in neurodegenerative diseases and therapeutic application of autophagy enhancers
Sovan Sarkar
Biochemical Society Transactions (2013) Vol. 41, Iss. 5, pp. 1103-1130
Closed Access | Times Cited: 345
The fate of chemoresistance in triple negative breast cancer (TNBC)
Elma Anna O'Reilly, Luke Gubbins, Shiva Sharma, et al.
BBA Clinical (2015) Vol. 3, pp. 257-275
Open Access | Times Cited: 340
Therapeutic targets in cancer cell metabolism and autophagy
Heesun Cheong, Chao Lü, Tullia Lindsten, et al.
Nature Biotechnology (2012) Vol. 30, Iss. 7, pp. 671-678
Open Access | Times Cited: 311
HDAC inhibitor‐based therapies: Can we interpret the code?
Maria I. New, Heidi Olzscha, Nicholas B. La Thangue
Molecular Oncology (2012) Vol. 6, Iss. 6, pp. 637-656
Open Access | Times Cited: 301
Targeting the mTOR pathway in hepatocellular carcinoma: Current state and future trends
Matthias S. Matter, Thomas Decaens, Jesper B. Andersen, et al.
Journal of Hepatology (2013) Vol. 60, Iss. 4, pp. 855-865
Open Access | Times Cited: 295
Autophagy inhibitors
Benoit Pasquier
Cellular and Molecular Life Sciences (2015) Vol. 73, Iss. 5, pp. 985-1001
Open Access | Times Cited: 283
Page 1 - Next Page

Scroll to top